Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …

Chemosensory scientists have been skeptical that reports of COVID-19 taste loss are
genuine, in part because before COVID-19 taste loss was rare and often confused with smell …

Background The aim of this study was to estimate the prevalence of self‐reported
chemosensory dysfunction in a study cohort of subjects who developed a mild‐to‐moderate …

Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …

Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …

Purpose The aim of the present study was to estimate the 1 year prevalence and recovery
rate of self-reported chemosensory dysfunction in a series of subjects with previous mild-to …

The sense of smell is interrelated with psychosocial functioning. Olfactory disorders often
decrease quality of life but treatment options for people with olfactory loss are limited …

Objective To characterize the clinical features, risk factors, symptom time‐course, and quality
of life implications for parosmia among coronavirus disease (COVID)‐related olfactory …

Background Loss of olfactory function is well recognised as a symptom of COVID‐19
infection, and the pandemic has resulted in a large number of individuals with abnormalities …

Background: The coronavirus disease 2019 (COVID-19) pandemic has been associated
with a dramatic increase in postviral olfactory dysfunction (PVOD) among patients who are …